Cancer of unknown primary origin (CUP)

Characteristics and common presentations

Patients with CUP typically present with signs attributable to metastases: enlarged lymph nodes, liver masses, bone pain or fractures, pulmonary nodules, or nonspecific systemic symptoms such as weight loss and fatigue. Common anatomic sites where metastases are first detected include:

• Lymph nodes (especially supraclavicular or cervical)
• Liver
• Bone
• Lungs or pleura
• Skin or subcutaneous tissue

Diagnostic approach

Establishing a diagnosis of CUP requires demonstration of metastatic cancer on histology or cytology while a primary tumor remains unidentified after thorough evaluation. The typical workup combines clinical assessment, imaging, pathology and, increasingly, molecular testing. Standard elements include:

• Detailed history and physical examination
• Cross-sectional imaging (CT or MRI) and, when appropriate, whole-body metabolic imaging such as PET
• Biopsy with histopathology and immunohistochemistry to suggest lineage
• Targeted molecular profiling or gene-expression assays in selected cases to suggest a tissue of origin or actionable alterations

These steps are designed to exclude obvious primary sites and to classify the tumour into prognostically useful subgroups. See general definitions: clinical definition, the concept of metastasis, and the role of biopsy in diagnosis.

Management and prognosis

Management strategies for CUP vary. Some patients belong to favourable-risk subsets that respond well to site-directed therapies and may achieve prolonged survival; others have aggressive, widely disseminated disease and receive systemic, empiric chemotherapy and supportive care. Recent advances in molecular diagnostics and targeted therapy aim to tailor treatment when an inferred primary or actionable mutation is identified. Overall prognosis is variable: a majority of CUP cases have a limited survival outlook, but a meaningful minority achieve longer-term control with appropriate interventions. For more on outcome patterns see prognosis summaries.

History and notable facts

The problem of occult primary tumors has been recognized for many decades. Improvements in imaging, pathology and molecular biology have reduced the proportion of cancers that remain truly occult, but CUP remains clinically important because it forces clinicians to balance extensive investigation with timely treatment. It is also a focus for research into molecular classification and precision oncology, since identifying the tissue of origin or targetable genetic changes can change therapy and outcomes.

Distinctions and clinical considerations

CUP differs from metastatic cancer of known primary both biologically and in management: it is a diagnosis of exclusion and encompasses diverse histologies and behaviours. Clinicians aim to identify treatable subsets, avoid unnecessary or futile tests, and integrate palliative care when appropriate. Enrollment in clinical trials and multidisciplinary evaluation are often recommended to optimize care.